Search alternatives:
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
small decrease » small increased (Expand Search)
all decrease » a decrease (Expand Search), fold decrease (Expand Search), awd decreased (Expand Search)
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
small decrease » small increased (Expand Search)
all decrease » a decrease (Expand Search), fold decrease (Expand Search), awd decreased (Expand Search)
-
601
<i>Kif15</i> deficient mice exhibit both depressive and manic behaviors in adulthood.
Published 2025Subjects: -
602
<i>Kif15</i> deficiency affects the expression of Gephyrin and GABRB1 in PFC and hippocampus.
Published 2025Subjects: -
603
Evogliptin attenuates the phenotypic switch of VSMCs during CER treatment by decreasing the osteogenesis-associated genes <i>in-vitro.</i>
Published 2025“…(B, C) Summarized bar graph showed EVO significantly decreased calcium deposition and calcium content in CER treated P<sub>i</sub>-induced VSMCs. …”
-
604
-
605
-
606
-
607
-
608
-
609
-
610
-
611
-
612
-
613
Table 2_Bibliometric analysis of global research on the clinical applications of aminoglycoside antibiotics: improving efficacy and decreasing risk.docx
Published 2025“…Avoiding prolonged dosing cycles and refraining from using AGs in patients with the m.1555 A > G gene variant can significantly mitigate the risk of ototoxicity. Future studies should examine the pharmacokinetic and pharmacodynamic targets of AGs and assess the efficacy and safety of administration by inhalation to improve efficacy and decrease risk.…”
-
614
Table 1_Bibliometric analysis of global research on the clinical applications of aminoglycoside antibiotics: improving efficacy and decreasing risk.docx
Published 2025“…Avoiding prolonged dosing cycles and refraining from using AGs in patients with the m.1555 A > G gene variant can significantly mitigate the risk of ototoxicity. Future studies should examine the pharmacokinetic and pharmacodynamic targets of AGs and assess the efficacy and safety of administration by inhalation to improve efficacy and decrease risk.…”
-
615
-
616
-
617
-
618
-
619
-
620